Back to Search
Start Over
sj-pdf-3-mso-10.1177_2055217321990852 - Supplemental material for Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study
- Publication Year :
- 2021
- Publisher :
- SAGE Journals, 2021.
-
Abstract
- Supplemental material, sj-pdf-3-mso-10.1177_2055217321990852 for Early MRI outcomes in participants with a first clinical demyelinating event at risk of multiple sclerosis in the ORACLE-MS study by Mark S Freedman Department of Medicine and the Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada, Patricia K Coyle Department of Neurology, Stony Brook University, Stony Brook, NY, USA, Giancarlo Comi Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Milan, Italy, Susan L Scarberry Sanford Health Multiple Sclerosis Center, Fargo, ND, USA, Doris Damian EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Yann Hyvert Merck KGaA, Darmstadt, Germany, Fernando Dangond EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany,Andrew Galazka, Dominic JackMerck KGaA, Darmstadt, Germany, Lori A Lebson EMD Serono, Inc, Rockland, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany, Thomas P Leist Comprehensive Multiple Sclerosis Center, Jefferson University Hospital, Philadelphia, PA, USA in Multiple Sclerosis Journal – Experimental, Translational and Clinical
- Subjects :
- FOS: Clinical medicine
110904 Neurology and Neuromuscular Diseases
Neuroscience
Subjects
Details
- ISSN :
- 20552173
- Database :
- OpenAIRE
- Accession number :
- edsair.doi...........781c14387887c0572454a504292f3def
- Full Text :
- https://doi.org/10.25384/sage.14120657.v1